The Mood and Anxiety Disorders Program is committed to discovering new, innovative, therapies for patients suffering from treatment-resistant mood disorders in order to improve the quality of life for these individuals and their families. The program pursues excellence in patient-oriented research, clinical care and education, and strives to share knowledge with community partners.

The clinic now includes repetitive transcranial stimulation (rTMS), an FDA-approved therapy for the treatment of medication resistant major depressive disorder. The rTMS protocol involves the application of magnetic pulses to target specific brain areas, with the aim of restoring optimal brain function. rTMS treatment is administered over a period of 5-6 weeks, in 20-minute sessions, Monday through Friday. The rTMS treatment is covered by most insurance plans. For more information, please call (713) 798-4857.

The faculty and staff of the Mood and Anxiety Disorders Program offer various clinical services in the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine.